The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells

Author：  

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.7, Iss.2, 2013-01, pp. : 555-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of low doses of estrone on the proliferation, differentiation and mineralization of osteoprecursor cells

By  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 681-684

Spandidos Publications

Access to resources Recommend Favorite

Effects of the combination of dexamethasone and fibroblast growth factor2 on differentiation of osteoprecursor cells

By  

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 659-662

Spandidos Publications

Access to resources Recommend Favorite

Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor α to vinblastine and vinorelbine

By Sui Meihua  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite

Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells

By              

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 327-337

Spandidos Publications

Access to resources Recommend Favorite

Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2

By          

International Journal of Oncology, Vol. 42, Iss. 6, 2013-01 ,pp. : 1993-2000

Spandidos Publications

Access to resources Recommend Favorite